Regulation of alternative splicing in obesity-induced hypertension

Zodwa Dlamini, Rodney Hull, Tshepiso J Makhafola, Mzwandile MbeleSouth African Medical Research Council/University of Pretoria Precision Prevention & Novel Drug Targets for HIV-Associated Cancers (PPNDTHAC) Extramural Unit, Pan African Cancer Research Institute (PACRI), Faculty of Health Sci...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Dlamini Z, Hull R, Makhafola TJ, Mbele M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	Obesity hypertension weight loss angiogenesis alternative splicing gene regulation Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/2e6cc479979940219286978c983b67ca
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:2e6cc479979940219286978c983b67ca
record_format	dspace
spelling	oai:doaj.org-article:2e6cc479979940219286978c983b67ca2021-12-02T07:14:53ZRegulation of alternative splicing in obesity-induced hypertension1178-7007https://doaj.org/article/2e6cc479979940219286978c983b67ca2019-08-01T00:00:00Zhttps://www.dovepress.com/regulation-of-alternative-splicing-in-obesity-induced-hypertension-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Zodwa Dlamini, Rodney Hull, Tshepiso J Makhafola, Mzwandile MbeleSouth African Medical Research Council/University of Pretoria Precision Prevention & Novel Drug Targets for HIV-Associated Cancers (PPNDTHAC) Extramural Unit, Pan African Cancer Research Institute (PACRI), Faculty of Health Sciences, University of Pretoria, Hatfield 0028, South AfricaCorrespondence: Zodwa DlaminiSouth African Medical Research Council/University of Pretoria Precision Prevention & Novel Drug Targets for HIV-Associated Cancers (PPNDTHAC) Extramural Unit, Pan African Cancer Research Institute (PACRI), Faculty of Health Sciences, University of Pretoria, South AfricaTel +27 3 18 199 334/5Email Zodwa.dlamini@up.ac.zaAbstract: Obesity is the result of genetics which predisposes an individual to obesity and environmental factors, resulting in excessive weight gain. A well-established linear relationship exists between hypertension and obesity. The combined burden of hypertension and obesity poses significant health and economic challenges. Many environmental factors and genetic traits interact to contribute to obesity-linked hypertension. These include excess sodium re-absorption or secretion by the kidneys, a hypertensive shift of renal-pressure and activation of the sympathetic nervous system. Most individuals suffering from hypertension need drugs in order to treat their raised blood pressure, and while a number of antihypertensive therapeutic agents are currently available, 50% of cases remain uncontrolled. In order to develop new and effective therapeutic agents combating obesity-induced hypertension, a thorough understanding of the molecular events leading to adipogenesis is critical. With the advent of whole genome and exome sequencing techniques, new genes and variants which can be used as markers for obesity and hypertension are being identified. This review examines the role played by alternative splicing (AS) as a contributing factor to the metabolic regulation of obesity-induced hypertension. Splicing mutations constitute at least 14% of the disease-causing mutations, thus implicating polymorphisms that effect splicing as indicators of disease susceptibility. The unique transcripts resulting from the alternate splicing of mRNA encoding proteins that play a key role in contributing to obesity would be vital to gain a proper understanding of the genetic causes of obesity. A greater knowledge of the genetic basis for obesity-linked hypertension will assist in the development of appropriate diagnostic tests as well as the identification of new personalized therapeutic targets against obesity-induced hypertension.Keywords: obesity, hypertension, weight loss, angiogenesis, alternative splicing, gene regulationDlamini ZHull RMakhafola TJMbele MDove Medical PressarticleObesityhypertensionweight lossangiogenesisalternative splicinggene regulationSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 12, Pp 1597-1615 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	Obesity hypertension weight loss angiogenesis alternative splicing gene regulation Specialties of internal medicine RC581-951
spellingShingle	Obesity hypertension weight loss angiogenesis alternative splicing gene regulation Specialties of internal medicine RC581-951 Dlamini Z Hull R Makhafola TJ Mbele M Regulation of alternative splicing in obesity-induced hypertension
description	Zodwa Dlamini, Rodney Hull, Tshepiso J Makhafola, Mzwandile MbeleSouth African Medical Research Council/University of Pretoria Precision Prevention & Novel Drug Targets for HIV-Associated Cancers (PPNDTHAC) Extramural Unit, Pan African Cancer Research Institute (PACRI), Faculty of Health Sciences, University of Pretoria, Hatfield 0028, South AfricaCorrespondence: Zodwa DlaminiSouth African Medical Research Council/University of Pretoria Precision Prevention & Novel Drug Targets for HIV-Associated Cancers (PPNDTHAC) Extramural Unit, Pan African Cancer Research Institute (PACRI), Faculty of Health Sciences, University of Pretoria, South AfricaTel +27 3 18 199 334/5Email Zodwa.dlamini@up.ac.zaAbstract: Obesity is the result of genetics which predisposes an individual to obesity and environmental factors, resulting in excessive weight gain. A well-established linear relationship exists between hypertension and obesity. The combined burden of hypertension and obesity poses significant health and economic challenges. Many environmental factors and genetic traits interact to contribute to obesity-linked hypertension. These include excess sodium re-absorption or secretion by the kidneys, a hypertensive shift of renal-pressure and activation of the sympathetic nervous system. Most individuals suffering from hypertension need drugs in order to treat their raised blood pressure, and while a number of antihypertensive therapeutic agents are currently available, 50% of cases remain uncontrolled. In order to develop new and effective therapeutic agents combating obesity-induced hypertension, a thorough understanding of the molecular events leading to adipogenesis is critical. With the advent of whole genome and exome sequencing techniques, new genes and variants which can be used as markers for obesity and hypertension are being identified. This review examines the role played by alternative splicing (AS) as a contributing factor to the metabolic regulation of obesity-induced hypertension. Splicing mutations constitute at least 14% of the disease-causing mutations, thus implicating polymorphisms that effect splicing as indicators of disease susceptibility. The unique transcripts resulting from the alternate splicing of mRNA encoding proteins that play a key role in contributing to obesity would be vital to gain a proper understanding of the genetic causes of obesity. A greater knowledge of the genetic basis for obesity-linked hypertension will assist in the development of appropriate diagnostic tests as well as the identification of new personalized therapeutic targets against obesity-induced hypertension.Keywords: obesity, hypertension, weight loss, angiogenesis, alternative splicing, gene regulation
format	article
author	Dlamini Z Hull R Makhafola TJ Mbele M
author_facet	Dlamini Z Hull R Makhafola TJ Mbele M
author_sort	Dlamini Z
title	Regulation of alternative splicing in obesity-induced hypertension
title_short	Regulation of alternative splicing in obesity-induced hypertension
title_full	Regulation of alternative splicing in obesity-induced hypertension
title_fullStr	Regulation of alternative splicing in obesity-induced hypertension
title_full_unstemmed	Regulation of alternative splicing in obesity-induced hypertension
title_sort	regulation of alternative splicing in obesity-induced hypertension
publisher	Dove Medical Press
publishDate	2019
url	https://doaj.org/article/2e6cc479979940219286978c983b67ca
work_keys_str_mv	AT dlaminiz regulationofalternativesplicinginobesityinducedhypertension AT hullr regulationofalternativesplicinginobesityinducedhypertension AT makhafolatj regulationofalternativesplicinginobesityinducedhypertension AT mbelem regulationofalternativesplicinginobesityinducedhypertension
_version_	1718399510434021376

Regulation of alternative splicing in obesity-induced hypertension

Ejemplares similares